Drug intelligence / Profile preview

glycitin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Glycitin is a naturally occurring soy isoflavone glycoside found in soybeans and soy-derived products such as tofu, soymilk, and soy sauce. As a phytoestrogen and selective estrogen receptor modulator (SERM), glycitin undergoes hydrolysis in the digestive tract by intestinal beta-glucosidases to form its active aglycone, glycitein, which binds to and activates estrogen receptors (with a preference for ER-beta). Glycitin has been shown to exhibit antioxidant, anti-inflammatory, anti-osteoporosis, and anti-aging properties. In research models, it promotes osteoblast differentiation and dermal fibroblast proliferation, potentially through the regulation of the TGF-beta and AKT signaling pathways. It is widely studied for its potential therapeutic benefits in menopausal symptom management, osteoporosis prevention, cardiovascular health, and lipid metabolism.

Other names
4',7-dihydroxy-6-methoxyisoflavone 7-O-glucoside7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-oneglycitein 7-O-beta-D-glucopyranosideglycitein7-O-beta-D-glucopyranosideglycitein-7-O-beta-D-glucopyranosideglycitein 7-O-beta-D-glucosideglycitein7-O-beta-D-glucosideglycitein-7-O-beta-D-glucosideglycitein 7-O-beta-glucosideglycitein7-O-beta-glucosideglycitein-7-O-beta-glucosideglycitein 7-O-glucosideglycitein7-O-glucosideglycitein-7-O-glucosideglycitein 7-glucosideglycitein7-glucosideglycitein-7-glucosideglycitein-7-beta-O-glucosideglycitein7-beta-O-glucosideglycitein 7-beta-O-glucoside
02

Targets

ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on glycitin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycitin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call